Active, Not Recruiting
Neoadjuvant SBRT Combined With Lenvatinib and Pucotenlimab for Resectable Hepatocellular Carcinoma
NCT06524466
- Conditions
- CNLC IIIA Stage, Macrovascular Invasion, Resectable Hepatocellular Carcinoma
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China